Articles Viewpoint May 2024 Uptown Squirrel Does Not Eat That Christy A. Rentmeester, PhD Marketing can undermine stewardship, and bioethics as a field should pay closer attention to antimicrobial resistance. AMA J Ethics. 2024;26(5):E429-433. doi: 10.1001/amajethics.2024.429. Case and Commentary May 2024 How Should We Manage Antimicrobial Resistance in Resource-Limited Settings? Elizabeth A. Gulleen, MD and Margaret Lubwama, MBChB, MMed Patients living in low-and middle-income countries (LMICs) shoulder the greatest burden of infections caused by antimicrobial-resistant pathogens. AMA J Ethics. 2024;26(5):E373-379. doi: 10.1001/amajethics.2024.373. History of Medicine May 2024 A Brief History of Antimicrobial Resistance Devin Hunt and Olivia S. Kates, MD, MA Resistance has dogged infectious disease treatment processes since we started using modern antimicrobials. AMA J Ethics. 2024;26(5):E408-417. doi: 10.1001/amajethics.2024.408. AMA Code Says Apr 2024 AMA Code of Medical Ethics’ Opinions Related to Global Medical Supply Chain Security Maura McGinnity When global medical supply chains fail, what should physicians do? AMA J Ethics. 2024;26(4):E303-305. doi: 10.1001/amajethics.2024.303. Medicine and Society Apr 2024 How Should Critical Medications Be Rationed During Shortages? Erin R. Fox, PharmD, MHA and Matthew K. Wynia, MD, MPH Recent increases in the frequency of shortages require more rationing by clinicians. AMA J Ethics. 2024;26(4):E334-340. doi: 10.1001/amajethics.2024.334. Case and Commentary Apr 2024 How Should Regulators and Manufacturers Prevent Avoidable Deaths of Children From Contaminated Cough Syrup? Kavitha Nallathambi, MPH, MBA and Amy B. Cadwallader, PhD Quality control testing is ethically and clinically key to increasing transparency in excipient supply chains. AMA J Ethics. 2024;26(4):E289-294. doi: 10.1001/amajethics.2024.289. Policy Forum Apr 2024 Surveillance and Security in US Medicine and Equipment Supply Chains Mahshid Abir, MD, MSc and Bradley Martin, PhD COVID-19 exposed vulnerabilities of US routine and emergency medicine and critical equipment supply chains that introduced urgent need for change. AMA J Ethics. 2024;26(4):E321-326. doi: 10.1001/amajethics.2024.321. Viewpoint Apr 2024 You Are What You Eat . . . and What You Take Orally, Intravenously, or Topically Christy A. Rentmeester, PhD Should we interrogate our bioproduct supply chains as we have begun interrogating our food supply chains? AMA J Ethics. 2024;26(4):E357-359. doi: 10.1001/amajethics.2024.357. From the Editor Apr 2024 Why Should Clinicians Care About Global Medical Supply Chain Security? Amy B. Cadwallader, PhD Many international experts exchange ideas about vulnerabilities of medical supply chains and how failure to make them more resilient is an ethics problem. AMA J Ethics. 2024;26(4):E277-281. doi: 10.1001/amajethics.2024.277. State of the Art and Science Apr 2024 Which Data Analytics Tool Should We Use to Evaluate Risk in Upstream Drug Supply Chains? Matt Christian, MSc and Wejdan Bagais, MSc Drug shortages are persistent and serious in the US, affecting care quality and costs. An early warning system could help. AMA J Ethics. 2024;26(4):E306-314. doi: 10.1001/amajethics.2024.306. Pagination First page « First Previous page ‹ Prev … Page 2 Page 3 Page 4 Page 5 Current page 6 Page 7 Page 8 Page 9 Page 10 … Next page Next › Last page Last »
Viewpoint May 2024 Uptown Squirrel Does Not Eat That Christy A. Rentmeester, PhD Marketing can undermine stewardship, and bioethics as a field should pay closer attention to antimicrobial resistance. AMA J Ethics. 2024;26(5):E429-433. doi: 10.1001/amajethics.2024.429.
Case and Commentary May 2024 How Should We Manage Antimicrobial Resistance in Resource-Limited Settings? Elizabeth A. Gulleen, MD and Margaret Lubwama, MBChB, MMed Patients living in low-and middle-income countries (LMICs) shoulder the greatest burden of infections caused by antimicrobial-resistant pathogens. AMA J Ethics. 2024;26(5):E373-379. doi: 10.1001/amajethics.2024.373.
History of Medicine May 2024 A Brief History of Antimicrobial Resistance Devin Hunt and Olivia S. Kates, MD, MA Resistance has dogged infectious disease treatment processes since we started using modern antimicrobials. AMA J Ethics. 2024;26(5):E408-417. doi: 10.1001/amajethics.2024.408.
AMA Code Says Apr 2024 AMA Code of Medical Ethics’ Opinions Related to Global Medical Supply Chain Security Maura McGinnity When global medical supply chains fail, what should physicians do? AMA J Ethics. 2024;26(4):E303-305. doi: 10.1001/amajethics.2024.303.
Medicine and Society Apr 2024 How Should Critical Medications Be Rationed During Shortages? Erin R. Fox, PharmD, MHA and Matthew K. Wynia, MD, MPH Recent increases in the frequency of shortages require more rationing by clinicians. AMA J Ethics. 2024;26(4):E334-340. doi: 10.1001/amajethics.2024.334.
Case and Commentary Apr 2024 How Should Regulators and Manufacturers Prevent Avoidable Deaths of Children From Contaminated Cough Syrup? Kavitha Nallathambi, MPH, MBA and Amy B. Cadwallader, PhD Quality control testing is ethically and clinically key to increasing transparency in excipient supply chains. AMA J Ethics. 2024;26(4):E289-294. doi: 10.1001/amajethics.2024.289.
Policy Forum Apr 2024 Surveillance and Security in US Medicine and Equipment Supply Chains Mahshid Abir, MD, MSc and Bradley Martin, PhD COVID-19 exposed vulnerabilities of US routine and emergency medicine and critical equipment supply chains that introduced urgent need for change. AMA J Ethics. 2024;26(4):E321-326. doi: 10.1001/amajethics.2024.321.
Viewpoint Apr 2024 You Are What You Eat . . . and What You Take Orally, Intravenously, or Topically Christy A. Rentmeester, PhD Should we interrogate our bioproduct supply chains as we have begun interrogating our food supply chains? AMA J Ethics. 2024;26(4):E357-359. doi: 10.1001/amajethics.2024.357.
From the Editor Apr 2024 Why Should Clinicians Care About Global Medical Supply Chain Security? Amy B. Cadwallader, PhD Many international experts exchange ideas about vulnerabilities of medical supply chains and how failure to make them more resilient is an ethics problem. AMA J Ethics. 2024;26(4):E277-281. doi: 10.1001/amajethics.2024.277.
State of the Art and Science Apr 2024 Which Data Analytics Tool Should We Use to Evaluate Risk in Upstream Drug Supply Chains? Matt Christian, MSc and Wejdan Bagais, MSc Drug shortages are persistent and serious in the US, affecting care quality and costs. An early warning system could help. AMA J Ethics. 2024;26(4):E306-314. doi: 10.1001/amajethics.2024.306.